Retinal Diseases: Clinical Presentation and Novel Treatments
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 1119
Special Issue Editors
Interests: ophthalmology; artificial intelligence; space medicine; optical coherence tomography; machine learning
Interests: retinal imaging; central serous chorioretinopathy; optic disc pit
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The retina plays a critical role in vision and quality of life. Preserving the retina in aging and disease is of the utmost importance. Within the past decade, therapies and imaging techniques for retinal diseases have emerged. Advances in imaging, including various optical coherence tomography (OCT) techniques, OCT angiography, multi confocal scanning laser ophthalmoscopy (MCSLO), and adaptive optics, have revolutionized how we can detect and understand retinal disease presentation. Various therapies that have revolutionized retinal disease management have also been introduced, such as multiple anti-VEGF intravitreal injection therapies for neovascular age-related macular degeneration. Research has also focused on various treatments, including gene therapy, complement component targeting, episcleral brachytherapy, subthreshold micropulse laser, and port delivery systems.
We are pleased to invite you to submit your work for a new Special Issue entitled “Retinal Diseases: Clinical Presentation and Novel Treatments”. We welcome the submission of original research articles or reviews that discuss the recent advances in understanding the clinical presentation of retinal disease and/or the novel treatments that have emerged for these diseases.
Dr. Joshua Ong
Dr. Jay Chhablani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retina
- clinical presentation
- age-related macular degeneration
- choroid
- chorioretinal disease
- optical coherence tomography
- novel therapies
